002589 瑞康醫藥
按盤價 
3.950 -0.270 (-6.398%)
3.950 -0.270 (-6.398%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.223 | 0.375 | 0.374 | -28.224 | 1.745 |
| 總資產報酬率 ROA (%) | 0.077 | 0.126 | 0.116 | -8.187 | 0.448 |
| 投入資產回報率 ROIC (%) | 0.096 | 0.161 | 0.149 | -11.048 | 0.655 | 邊際利潤分析 |
| 銷售毛利率 (%) | 11.548 | 10.999 | 10.294 | 13.582 | 18.229 |
| 營業利潤率 (%) | 0.306 | 0.321 | -1.576 | -13.941 | 2.370 |
| 息稅前利潤/營業總收入 (%) | 1.993 | 2.115 | -0.035 | -11.221 | 4.409 |
| 淨利潤/營業總收入 (%) | 0.499 | 0.515 | 0.398 | -14.123 | 1.814 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -1,071.928 | -127.548 | 152.267 | 17.889 | 109.154 |
| 價值變動淨收益/利潤總額(%) | 349.514 | 305.181 | -132.867 | 52.297 | 44.804 |
| 營業外收支淨額/利潤總額(%) | -263.633 | 38.577 | 6.485 | 1.565 | -7.324 | 償債能力分析 |
| 流動比率 (X) | 1.111 | 1.115 | 1.072 | 1.028 | 1.252 |
| 速動比率 (X) | 1.037 | 1.041 | 0.968 | 0.952 | 1.127 |
| 資產負債率 (%) | 64.419 | 64.404 | 66.264 | 68.627 | 63.279 |
| 帶息債務/全部投入資本 (%) | 56.536 | 56.199 | 57.040 | 62.539 | 58.498 |
| 股東權益/帶息債務 (%) | 76.149 | 77.142 | 74.632 | 59.404 | 69.589 |
| 股東權益/負債合計 (%) | 54.168 | 53.719 | 49.202 | 42.981 | 45.301 |
| 利息保障倍數 (X) | 1.044 | 1.328 | -0.021 | -3.815 | 2.003 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 189.732 | 172.360 | 176.438 | 210.502 | 205.205 |
| 存貨周轉天數 (天) | 40.303 | 47.063 | 51.787 | 51.136 | 52.320 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 10/12/2025 11:26 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
